Literature DB >> 10487394

Changing prescribing in the light of tolerability concerns: how is this best achieved?

C S de Vries1, C A Duggan, T F Tromp, L T de Jong-van den Berg.   

Abstract

Despite our knowledge regarding the efficacy, tolerability and optimal use of drugs, suboptimal prescribing still occurs. In view of all the factors that influence prescribing, this is not surprising. The focus of drug tolerability has changed from 'choosing the best alternative' when a drug is prescribed, to a balanced decision incorporating various different treatments from separate healthcare providers. This article reviews strategies that may influence prescribing behaviour and discusses practical considerations for achieving optimal prescribing in view of tolerability concerns. The patient has a major influence on prescribing and, with the current diversification of healthcare, the patient now controls prescribing behaviour more than ever before. Communication between healthcare providers consequently assumes a vital role. If messages are to be coherent and transferable, it is increasingly important that healthcare workers communicate effectively with one another regarding patients, prescribing patterns, and drug tolerability issues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487394     DOI: 10.2165/00002018-199921030-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.228


  53 in total

Review 1.  Optimal medication use in elders. Key to successful aging.

Authors:  M Monane; S Monane; T Semla
Journal:  West J Med       Date:  1997-10

2.  The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey.

Authors:  N Britten; O Ukoumunne
Journal:  BMJ       Date:  1997-12-06

3.  Evaluation of computer support for prescribing (CAPSULE) using simulated cases.

Authors:  R T Walton; C Gierl; P Yudkin; H Mistry; M P Vessey; J Fox
Journal:  BMJ       Date:  1997-09-27

Review 4.  Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.

Authors: 
Journal:  Hypertens Res       Date:  1997-06       Impact factor: 3.872

5.  Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents.

Authors:  C A Mustard; T Mayer
Journal:  Am J Epidemiol       Date:  1997-04-15       Impact factor: 4.897

6.  Economic and policy analysis of university-based drug "detailing".

Authors:  S B Soumerai; J Avorn
Journal:  Med Care       Date:  1986-04       Impact factor: 2.983

7.  Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.

Authors:  W Yamreudeewong; J V Johnson; T G Cassidy; J T Berg
Journal:  Pharmacotherapy       Date:  1996 Nov-Dec       Impact factor: 4.705

8.  Antibiotics and respiratory infections: do antibiotic prescriptions improve outcomes?

Authors:  R M Hamm; R J Hicks; D A Bemben
Journal:  J Okla State Med Assoc       Date:  1996-08

Review 9.  New developments in bronchodilator therapy.

Authors:  H S Nelson
Journal:  Curr Opin Pulm Med       Date:  1996-01       Impact factor: 3.155

10.  The use of beta-agonists and the risk of death and near death from asthma.

Authors:  W O Spitzer; S Suissa; P Ernst; R I Horwitz; B Habbick; D Cockcroft; J F Boivin; M McNutt; A S Buist; A S Rebuck
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

View more
  1 in total

1.  Pharmacovigilance: a worldwide master key for drug safety monitoring.

Authors:  G Jeetu; G Anusha
Journal:  J Young Pharm       Date:  2010-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.